ImmunoGen, Inc.

Invesco Ltd.

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/13/2024

Shares

885,323

Value ($000)

26,250

Weight

0.0%

2013 Q4 - 2023 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/13/2024	26,250	0.0%	885,323	12/31/2023
2023 Q3	11/13/2023	17,237	0.0%	1,086,168	9/30/2023
2023 Q2	8/11/2023	19,544	0.0%	1,035,705	6/30/2023
2023 Q1	5/12/2023	699	0.0%	182,068	3/31/2023
2022 Q4	2/13/2023	452	0.0%	91,080	12/31/2022
2022 Q3	11/14/2022	437	0.0%	91,459	9/30/2022
2022 Q2	8/15/2022	389	0.0%	86,397	6/30/2022
2022 Q1	5/16/2022	402	0.0%	84,287	3/31/2022
2021 Q4	2/14/2022	624	0.0%	84,022	12/31/2021
2021 Q3	11/15/2021	524	0.0%	92,241	9/30/2021
2021 Q2	8/17/2021	529	0.0%	80,231	6/30/2021
2021 Q1	5/17/2021	395	0.0%	48,782	3/31/2021
2020 Q4	2/16/2021	281	0.0%	43,528	12/31/2020
2020 Q3	11/16/2020	114	0.0%	31,664	9/30/2020
2020 Q2	8/14/2020	6,230	0.0%	1,354,400	6/30/2020
2020 Q1	5/15/2020	70	0.0%	20,236	3/31/2020
2019 Q4	2/14/2020	2,078	0.0%	407,014	12/31/2019
2014 Q1	5/15/2014	10,948	0.0%	733,259	3/31/2014
2013 Q4	2/13/2014	8,071	0.0%	550,227	12/31/2013